Products
Online Inquiry
Nocodazole (R17934)
Cat. No.:
OB0225WX-2515
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Nocodazole (R17934) is a rapidly reversible inhibitor of microtubule polymerization that also targets Abl kinase isoforms, including mutant E255K and T315I, with sub-micromolar IC50 values.
Synonym:
Oncodazole, NSC238159; 31430-18-9; Nocodazole; R 17934; Nocodazol; Nocodazolum; Methyl N-[6-(thiophene-2-carbonyl)-1H-benzimidazol-2-yl]carbamate; methyl (5-(thiophene-2-carbonyl)-1H-benzo[d]imidazol-2-yl)carbamate; NSC 238159; NSC-238159; R 17,934; Methyl 5-(2-thenoyl)-2-benzimidazolecarbamate; R-17934; Methyl N-(5-thenoyl-2-benzimidazolyl)carbamate; Methyl [5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl]carbamate; MFCD00005588; N-(5-(2-Thenoyl)-2-benzimidazolyl)carbamic acid methyl ester; NSC238159; Methyl (5-(2-thienylcarbonyl))-1H-benzimidazole-2-ylcarbamate; 2-Benzimidazolecarbamic acid, 5-(2-thienylcarbonyl)-, methyl ester; 2-Benzimidazolecarbamic acid, 5-(2-thenoyl)-, methyl ester; Methyl (5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl)carbamate; methyl (6-(thiophene-2-carbonyl)-1H-benzo[d]imidazol-2-yl)carbamate; Carbamic acid, (5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl)-, methyl ester; Carbamic acid, (5-(2-thienylcarbonyl)-1H-benzimidazole-2-yl)-, methyl ester; [5-(2-Thienylcarbonyl)-1H-benzimidazol-2-yl]-carbamic acid methyl ester; Methyl 5-(2-thienoyl)-2-benzimidazolecarbamate; 2-Benzimidazolecarbamic acid, 5-(2-thienoyl)-, methyl ester; Methyl [5-(2-thienylcarbonyl)-1H- benzimidazol-2-yl]carbamate; methyl [6-(thiophen-2-ylcarbonyl)-1H-benzimidazol-2-yl]carbamate; N-(5-(2-Thienoyl)-2-benzimidazolyl)carbamic acid methyl ester; methyl N-[5-(thiophene-2-carbonyl)-1H-benzimidazol-2-yl]carbamate
CAS No.:
31430-18-9
Compound CID:
4122
Formula:
C14H11N3O3S
Formula Weight:
301.32
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Nocodazole (R17934) is used in cell biology as a microtubule-destabilizing agent to investigate the dynamics of the cytoskeleton, mitosis regulation, and the induction of cell cycle arrest in the G2/M phase.
Library Information
Target:
Bcr-Abl; Microtubule
Receptor:
Bcr-Abl; Microtubule
Pathways:
Cytoskeletal signaling
Plate Number:
L6700-04
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
7 mg/mL; 23.23 mM
ALogP:
3.008
HBA_Count:
4
HBD_Count:
2
Rotatable Bond:
4





